Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebocontrolled trial evaluating its effects 5-6 years after completion of the primary series (vol 16, pg 523, 2019)
作者:
发布时间
2021-11-26
- 浏览0

Human vaccines & immunotherapeutics.
2819-2819页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文